Helab:Research: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
Xiaoming He (talk | contribs) No edit summary |
Xiaoming He (talk | contribs) No edit summary |
||
Line 7: | Line 7: | ||
*Microencapsulation of living cells (including oocytes, pluripotent stem cells, mesenchymal stem cells, primary cells, and bacterial cells) using electrospray and microfluidic devices for reproductive and regenerative medicine, biobanking, and treating infectious diseases | *Microencapsulation of living cells (including oocytes, pluripotent stem cells, mesenchymal stem cells, primary cells, and bacterial cells) using electrospray and microfluidic devices for reproductive and regenerative medicine, biobanking, and treating infectious diseases | ||
*Development of nanoscale polymeric and hybrid biomaterials that are responsive to environmental stimuli (e.g., pH, temperature, and light) for | *Development of nanoscale polymeric and hybrid biomaterials that are responsive to environmental stimuli (e.g., pH, temperature, and light) for delivering therapeutic agents (e.g., drugs and genes) to facilitate cell-based medicine and destroy cancer | ||
*Development of computational models to understand the biotransport phenomena in microencapsulating and banking living cells and tissues | *Development of computational models to understand the biotransport phenomena in microencapsulating and banking living cells and tissues |
Revision as of 08:00, 1 July 2016
Research in our lab is focused on developing multiscale biomaterials to engineer living cells and tissues for two applications: Cancer treatment and cell-based medicine. The following are specific projects that are ongoing in our lab:
- Microencapsulation of living cells (including oocytes, pluripotent stem cells, mesenchymal stem cells, primary cells, and bacterial cells) using electrospray and microfluidic devices for reproductive and regenerative medicine, biobanking, and treating infectious diseases
- Development of nanoscale polymeric and hybrid biomaterials that are responsive to environmental stimuli (e.g., pH, temperature, and light) for delivering therapeutic agents (e.g., drugs and genes) to facilitate cell-based medicine and destroy cancer
- Development of computational models to understand the biotransport phenomena in microencapsulating and banking living cells and tissues
We are so grateful for the support of our research and education effort by the following sponsors:
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
National Institutes of Health (NIH)
National Science Foundation (NSF)
Wendy Will Case Cancer Fund (WWCCF)
University of South Carolina Research Foundation
The Ohio State University (OSU) Research Foundation